Phytocannabinoids (news – undated) http://www.news-medical.net/health/P...nabinoids.aspx
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. (full – 2002) http://jpet.aspetjournals.org/content/301/3/1020.long
Endocannabinoids and related fatty acid derivatives in pain modulation. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15233865
Role of the endocannabinoid system in the development of tolerance to alcohol (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15923084
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
GPR55: a new member of the cannabinoid receptor clan? (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
The orphan receptor GPR55 is a novel cannabinoid receptor. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs). (full – 2008) https://www.jstage.jst.go.jp/article.../33_5_555/_pdf
Role of endocannabinoids in cardiovascular shock. (full – 2008) http://www.jpp.krakow.pl/journal/arc...s8_article.pdf
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. (full – 2008) http://molpharm.aspetjournals.org/content/73/2/441.long
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. (full – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
The role of the CB1 receptor in the regulation of sleep. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full – 2009) http://www.scielo.br/scielo.php?scri...lng=en&nrm=iso
Endogenous cannabinoids in liver disease: Many darts for a single target (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes (abst – 2011) https://www.thieme-connect.com/ejour...s-0030-1269511
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669693/
Optimized synthesis and characterization of N-acylethanolamines and Oacylethanolamines, important family of lipid-signalling molecules. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/2...?dopt=Abstract
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. (full– 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599339/
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Mechanism of platelet activation induced by endocannabinoids in blood and plasma. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23789792
Tricks and Tracks in the Identification and Quantification of Endocannabinoids (abst – 2013) http://onlinelibrary.wiley.com/doi/1...23407/abstract
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. (full – 2002) http://jpet.aspetjournals.org/content/301/3/1020.long
Endocannabinoids and related fatty acid derivatives in pain modulation. (abst – 2002) http://www.ncbi.nlm.nih.gov/pubmed/12505698
Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery. (abst – 2004) http://www.ncbi.nlm.nih.gov/pubmed/15233865
Role of the endocannabinoid system in the development of tolerance to alcohol (full – 2005) http://alcalc.oxfordjournals.org/content/40/1/15.long
Fatty acid amidohydrolase in human neocortex-activity in epileptic and non-epileptic brain tissue and inhibition by putative endocannabinoids. (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15923084
Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor (abst – 2005) http://www.ncbi.nlm.nih.gov/pubmed/15588725
GPR55: a new member of the cannabinoid receptor clan? (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
The orphan receptor GPR55 is a novel cannabinoid receptor. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...7/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...1/?tool=pubmed
Virodhamine and CP55,940 modulate cAMP production and IL-8 release in human bronchial epithelial cells. (full – 2007) http://www.ncbi.nlm.nih.gov/pmc/arti...4/?tool=pubmed
Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs). (full – 2008) https://www.jstage.jst.go.jp/article.../33_5_555/_pdf
Role of endocannabinoids in cardiovascular shock. (full – 2008) http://www.jpp.krakow.pl/journal/arc...s8_article.pdf
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. (full – 2008) http://molpharm.aspetjournals.org/content/73/2/441.long
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product. (full – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
The role of the CB1 receptor in the regulation of sleep. (abst – 2008) http://www.ncbi.nlm.nih.gov/pubmed/18514375
Unconventional neurotransmitters, neurodegeneration and neuroprotection (full – 2009) http://www.scielo.br/scielo.php?scri...lng=en&nrm=iso
Endogenous cannabinoids in liver disease: Many darts for a single target (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/19758727
The novel endocannabinoid virodhamine selectively induces cell death in hepatic stellate cells but not in hepatocytes (abst – 2011) https://www.thieme-connect.com/ejour...s-0030-1269511
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669693/
Optimized synthesis and characterization of N-acylethanolamines and Oacylethanolamines, important family of lipid-signalling molecules. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/2...?dopt=Abstract
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. (full– 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599339/
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Mechanism of platelet activation induced by endocannabinoids in blood and plasma. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23789792
Tricks and Tracks in the Identification and Quantification of Endocannabinoids (abst – 2013) http://onlinelibrary.wiley.com/doi/1...23407/abstract
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431